Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo
Authors
Keywords
-
Journal
BRITISH JOURNAL OF DERMATOLOGY
Volume 174, Issue 6, Pages 1318-1326
Publisher
Wiley
Online
2016-01-23
DOI
10.1111/bjd.14416
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo
- (2015) L Yang et al. ACTA DERMATO-VENEREOLOGICA
- CXCR3 ligands in disease and therapy
- (2015) Katrien Van Raemdonck et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Vitiligo
- (2015) Khaled Ezzedine et al. LANCET
- Circulating Autoantibodies and Autoimmune Comorbidities in Vitiligo Patients: A Multicenter Italian Study
- (2014) Vito Ingordo et al. DERMATOLOGY
- IP-10 in Autoimmune Thyroiditis
- (2014) I. Ruffilli et al. HORMONE AND METABOLIC RESEARCH
- Assessment of tissue FoxP3+, CD4+and CD8+T-cells in active and stable nonsegmental vitiligo
- (2014) Marwa Abdallah et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- The Biological Functions, Structure and Sources of CXCL10 and Its Outstanding Part in the Pathophysiology of Multiple Sclerosis
- (2014) Reza Vazirinejad et al. NEUROIMMUNOMODULATION
- Current aspects of vitiligo genetics
- (2014) Rafał Czajkowski et al. Postepy Dermatologii i Alergologii
- CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo
- (2014) M. Rashighi et al. Science Translational Medicine
- Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset
- (2014) Paul R Dominguez-Gutierrez et al. ARTHRITIS RESEARCH & THERAPY
- Correlation of CXCL10, Tumor Necrosis Factor Receptor Type II, and Galectin 9 With Disease Activity in Juvenile Dermatomyositis
- (2014) F. Bellutti Enders et al. Arthritis & Rheumatology
- Melanocyte-specific CD8+T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo
- (2013) S. You et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Innate immune mechanisms in vitiligo: danger from within
- (2013) Jillian M Richmond et al. CURRENT OPINION IN IMMUNOLOGY
- Comorbidities Associated with Vitiligo: A Ten-Year Retrospective Study
- (2013) Vaneeta M. Sheth et al. DERMATOLOGY
- Involvement of Interferon-Gamma Genetic Variants and Intercellular Adhesion Molecule-1 in Onset and Progression of Generalized Vitiligo
- (2013) Mitesh Dwivedi et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Decreased regulatory T-cells and CD4+/CD8+ratio correlate with disease onset and progression in patients with generalized vitiligo
- (2013) Mitesh Dwivedi et al. Pigment Cell & Melanoma Research
- IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus
- (2012) Thomas Rose et al. ANNALS OF THE RHEUMATIC DISEASES
- Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms
- (2012) A. Gey et al. BRITISH JOURNAL OF DERMATOLOGY
- Increased Expression of Cxcr3 and Its Ligands, Cxcl9 and Cxcl10, during the Development of Alopecia Areata in the Mouse
- (2012) Caroline G. McPhee et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-γ for Autoreactive CD8+ T-Cell Accumulation in the Skin
- (2012) John E. Harris et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference
- (2012) K. Ezzedine et al. Pigment Cell & Melanoma Research
- Increased Tumor Necrosis Factor (TNF)-α and Its Promoter Polymorphisms Correlate with Disease Progression and Higher Susceptibility towards Vitiligo
- (2012) Naresh C. Laddha et al. PLoS One
- Recent progress in the genetics of generalized vitiligo
- (2011) Richard A. Spritz Journal of Genetics and Genomics
- IFN-γ, IL-21, and IL-10 Co-Expression in Evolving Autoimmune Vitiligo Lesions of Smyth Line Chickens
- (2011) Fengying Shi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Six Decades of Vitiligo Genetics: Genome-Wide Studies Provide Insights into Autoimmune Pathogenesis
- (2011) Richard A. Spritz JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Romanian Population Isolate With High Frequency of Vitiligo and Associated Autoimmune Diseases
- (2010) S. A. Birlea et al. ARCHIVES OF DERMATOLOGY
- Mechanisms of Spatial and Temporal Development of Autoimmune Vitiligo in Tyrosinase-Specific TCR Transgenic Mice
- (2010) Randal K. Gregg et al. JOURNAL OF IMMUNOLOGY
- CXCR3, Inflammation, and Autoimmune Diseases
- (2009) Stéphanie Lacotte et al. Annals of the New York Academy of Sciences
- Chemokine Receptors in T-Cell-Mediated Diseases of the Skin
- (2009) Anke S. Lonsdorf et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients
- (2009) Jasper G. van den Boorn et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients
- (2008) Zheng Zhang et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation